CFTR and cystic fibrosis: Eluforsen (formerly QR-010) is an antisense oligonucleotide binding the mRNA region encoding the Phe508del CFTR mutation, and was developed clinically by ProQR Therapeutics for inhalation to patients with F508del CF.